ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1020

The Impact Of Diagnostic Decision Rules Used In Administrative Healthcare Databases On The Frequency Of Rheumatoid Arthritis and Systemic Lupus Erythematosus

John G. Hanly1, Kara Thompson2 and Chris Skedgel1, 1Division of Rheumatology, Dalhousie University and Capital Health, Halifax, NS, Canada, 2Department of Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Fall Risk, population studies and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose: To compare the incidence and prevalence of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) in administrative databases using different diagnostic decision rules.

Methods: A retrospective cohort study was performed using administrative health care data from a population of 1 million people with access to universal healthcare. Information was available on hospital discharges and physician billings over a 13 year period. Each RA and SLE case was matched 4:1 by age and gender to randomly selected controls. Seven decision rules, validated against the diagnosis confirmed by a rheumatologist, were used to identify RA and SLE cases and to examine the incidence and prevalence of both diseases.

Results: The overall accuracy of the decision rules for RA cases varied between 68.9-82.9% with a kappa statistic between 0.26-0.53. The sensitivity varied from 20.7-94.8% and the specificity between 62.5-98.5%. For SLE the overall accuracy of the decision rules varied between 88.2-95.6% with a kappa statistic between 0.53-0.86. The sensitivity varied from 41.0-86.6% and the specificity between 92.4-99.9%. The number of incident cases per year was between 176-1610 (0.02 – 0.17% population) for RA and between 29-255 (0.003 – 0.027% population) for SLE. The number of prevalent cases per year was between 1384-5722 (0.15 – 0.61% population) for RA and between 172-920 for SLE (0.018 – 0.098% population).

Conclusion: The performance of decision rules for the identification of incident and prevalent RA and SLE cases in administrative healthcare databases is variable and should be considered when compareing results across studies.

 


Disclosure:

J. G. Hanly,
None;

K. Thompson,
None;

C. Skedgel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-diagnostic-decision-rules-used-in-administrative-healthcare-databases-on-the-frequency-of-rheumatoid-arthritis-and-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology